Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.230
+0.010 (0.82%)
At close: Aug 25, 2026, 4:00 PM EDT
1.230
0.00 (0.00%)
Pre-market: Aug 26, 2026, 7:00 AM EDT
Co-Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.52 | 0.42 | 0.77 | 0.99 | 34.22 | 97.89 |
Other Revenue | 0.2 | 0.2 | 3.15 | 5.82 | - | - |
| 0.72 | 0.62 | 3.92 | 6.81 | 34.22 | 97.89 | |
Revenue Growth | -28.12% | -84.10% | -42.53% | -80.09% | -65.04% | 31.30% |
Cost of Revenue | 0.41 | 0.22 | 1 | 4.18 | 5.48 | 11.57 |
Gross Profit | 0.31 | 0.4 | 2.92 | 2.63 | 28.74 | 86.31 |
Selling, General & Admin | 9.74 | 11.44 | 20.64 | 21.14 | 21.61 | 24.95 |
Research & Development | 19.67 | 19.14 | 20.98 | 22.96 | 17.44 | 14.96 |
Operating Expenses | 30.4 | 31.68 | 43 | 45.33 | 40.33 | 40.25 |
Operating Income | -30.08 | -31.28 | -40.08 | -42.71 | -11.59 | 46.06 |
Interest & Investment Income | 0.29 | 0.29 | 1.09 | 1.16 | 0.7 | 0.05 |
Earnings From Equity Investments | -0.1 | -0.05 | -0.19 | 0.1 | -0.33 | -0.43 |
EBT Excluding Unusual Items | -29.89 | -31.04 | -39.18 | -41.44 | -11.22 | 45.68 |
Impairment of Goodwill | - | - | - | - | -15.39 | - |
Gain (Loss) on Sale of Investments | 0.04 | 0.68 | 0.87 | 2.24 | - | - |
Gain (Loss) on Sale of Assets | -0.07 | -0.08 | 0.01 | -0 | -0.14 | -0.04 |
Asset Writedown | -18.88 | -18.88 | - | - | - | - |
Other Unusual Items | 0.12 | 0.81 | 0.71 | 1.09 | 7.9 | - |
Pretax Income | -48.68 | -48.51 | -37.58 | -38.11 | -18.85 | 45.64 |
Income Tax Expense | -1.62 | -1.62 | 0.06 | -2.78 | -4.61 | 8.98 |
Net Income | -47.06 | -46.9 | -37.64 | -35.33 | -14.24 | 36.66 |
Net Income to Common | -47.06 | -46.9 | -37.64 | -35.33 | -14.24 | 36.66 |
Net Income Growth | - | - | - | - | - | -13.70% |
Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Change | 130.53% | 31.55% | 3.37% | -6.77% | 5.27% | 6.80% |
EPS (Basic) | -19.36 | -35.25 | -37.22 | -36.12 | -13.57 | 38.09 |
EPS (Diluted) | -19.36 | -35.25 | -37.22 | -36.12 | -13.57 | 36.90 |
EPS Growth | - | - | - | - | - | -19.08% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -27.47 | -29.84 | -29.9 | -23.45 | 5.14 | 40.41 |
Free Cash Flow Per Share | -11.30 | -22.43 | -29.57 | -23.97 | 4.90 | 40.54 |
Gross Margin | 43.48% | 64.28% | 74.48% | 38.56% | 83.98% | 88.17% |
Operating Margin | -4170.14% | -5025.53% | -1023.75% | -626.92% | -33.88% | 47.06% |
Profit Margin | -6523.05% | -7533.62% | -961.37% | -518.68% | -41.61% | 37.45% |
Free Cash Flow Margin | -3808.03% | -4793.17% | -763.79% | -344.20% | 15.02% | 41.28% |
EBITDA | -29.09 | -30.18 | -38.7 | -41.48 | -10.31 | 46.4 |
EBITDA Margin | - | - | - | - | -30.13% | 47.40% |
D&A For EBITDA | 0.99 | 1.11 | 1.38 | 1.23 | 1.28 | 0.34 |
EBIT | -30.08 | -31.28 | -40.08 | -42.71 | -11.59 | 46.06 |
EBIT Margin | - | - | - | - | -33.88% | 47.06% |
Effective Tax Rate | - | - | - | - | - | 19.67% |
Revenue as Reported | 0.72 | 0.62 | 3.92 | 6.81 | 34.22 | - |